124 related articles for article (PubMed ID: 8338750)
1. The cutaneous corticosteroid vasoconstriction assay: a reflectance spectroscopic and laser-Doppler flowmetric study.
Andersen P; Milioni K; Maibach H
Br J Dermatol; 1993 Jun; 128(6):660-5. PubMed ID: 8338750
[TBL] [Abstract][Full Text] [Related]
2. A corticosteroid, a non-steroidal anti-inflammatory drug and an antihistamine modulate in vivo vascular reactions before and during post-occlusive hyperaemia.
Andersen PH; Broichmann PW; Maibach H
Br J Dermatol; 1993 Feb; 128(2):137-42. PubMed ID: 8457446
[TBL] [Abstract][Full Text] [Related]
3. Vasoconstrictive effect of topical applied corticosteroids measured by laser doppler imaging and reflectance spectroscopy.
Sommer A; Lucassen GW; Houben AJ; Neumann MH
Microvasc Res; 2003 May; 65(3):152-9. PubMed ID: 12711256
[TBL] [Abstract][Full Text] [Related]
4. Onset of the vasoconstrictor effect of diflucortolone valerate, betamethasone valerate, and fluocinolone acetonide ointments applied for varying periods under occlusive dressings.
Szadurski J; Renz F; Gasser D
Dermatologica; 1976; 153(4):236-42. PubMed ID: 1017533
[TBL] [Abstract][Full Text] [Related]
5. Ultraviolet B dose-dependent inflammation in humans: a reflectance spectroscopic and laser Doppler flowmetric study using topical pharmacologic antagonists on irradiated skin.
Andersen PH; Abrams K; Maibach H
Photodermatol Photoimmunol Photomed; 1992 Feb; 9(1):17-23. PubMed ID: 1390118
[TBL] [Abstract][Full Text] [Related]
6. Vasoconstrictor and the anti-inflammatory effects of 7 corticosteroids.
Crijns MB; Nater JP; van Oostveen F; van der Valk PG
Contact Dermatitis; 1984 Aug; 11(2):108-11. PubMed ID: 6488765
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the vasoconstrictive effects of topical steroids by laser-Doppler-perfusion-imaging.
Sommer A; Veraart J; Neumann M; Kessels A
Acta Derm Venereol; 1998 Jan; 78(1):15-8. PubMed ID: 9498019
[TBL] [Abstract][Full Text] [Related]
8. Quantification of skin-colour changes induced by topical corticosteroid preparations using the Minolta Chroma Meter.
Queille-Roussel C; Poncet M; Schaefer H
Br J Dermatol; 1991 Mar; 124(3):264-70. PubMed ID: 2018732
[TBL] [Abstract][Full Text] [Related]
9. A time correlation study between reflectance spectroscopic cutaneous vasoconstriction and plasma corticosteroid concentration.
Andersen P; Kubota K; Lo ES; Huttinot G; Maibach H
Br J Dermatol; 1995 Jan; 132(1):59-65. PubMed ID: 7756152
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic potencies of novel thiol ester corticosteroids RS-85095 and RS-21314 as compared with clobetasol 17-propionate and fluocinonide.
Ong JT; Poulsen BJ; Akers WA; Scholtz JR; Genter FC; Kertesz DJ
Arch Dermatol; 1989 Dec; 125(12):1662-5. PubMed ID: 2589861
[TBL] [Abstract][Full Text] [Related]
11. Comparison of skin atrophy and vasoconstriction due to mometasone furoate, methylprednisolone and hydrocortisone.
Hoffmann K; Auer T; Stücker M; Hoffmann A; Altmeyer P
J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):137-42. PubMed ID: 9553910
[TBL] [Abstract][Full Text] [Related]
12. Parallel intraindividual evaluation of the vasoconstrictory action and the anti-allergic activity of topical corticosteroids.
Seidenari S; Di Nardo A; Mantovani L; Giannetti A
Exp Dermatol; 1997 Apr; 6(2):75-80. PubMed ID: 9209888
[TBL] [Abstract][Full Text] [Related]
13. A comparison of techniques to assess skin blanching following the topical application of glucocorticoids.
Noon JP; Evans CE; Haynes WG; Webb DJ; Walker BR
Br J Dermatol; 1996 May; 134(5):837-42. PubMed ID: 8736322
[TBL] [Abstract][Full Text] [Related]
14. Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay.
Borelli C; Gassmueller J; Fluhr JW; Nietsch KH; Schinzel S; Korting HC
Skin Pharmacol Physiol; 2008; 21(3):181-7. PubMed ID: 18523415
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the bioactivity of mometasone furoate 0.1% fatty cream, betamethasone dipropionate 0.05% cream and betamethasone valerate 0.1% cream in humans. Inhibition of UV-B-induced inflammation monitored by laser Doppler blood flowmetry.
Bjerring P
Skin Pharmacol; 1993; 6(3):187-92. PubMed ID: 8274288
[TBL] [Abstract][Full Text] [Related]
16. The chamber vasoconstrictor assay. I. Comparison with occluded and unoccluded tests using four corticosteroids.
Somerma S
Clin Exp Dermatol; 1980 Jun; 5(2):191-6. PubMed ID: 7438514
[No Abstract] [Full Text] [Related]
17. [Age-dependent differences in the pharmacodynamic effect of topically applied Corticosteroids].
Koch EM; Ott R; Koehler CO
Arzneimittelforschung; 1986 Oct; 36(10):1540-4. PubMed ID: 3814215
[TBL] [Abstract][Full Text] [Related]
18. Reflectance spectrophotometric quantification of skin colour changes induced by topical corticosteroid preparations.
Feather JW; Ryatt KS; Dawson JB; Cotterill JA; Barker DJ; Ellis DJ
Br J Dermatol; 1982 Apr; 106(4):437-43. PubMed ID: 7073967
[TBL] [Abstract][Full Text] [Related]
19. Postural skin colour changes during the corticosteroid blanching assay.
Henry F; Fumal I; Piérard GE
Skin Pharmacol Appl Skin Physiol; 1999; 12(4):199-210. PubMed ID: 10420140
[TBL] [Abstract][Full Text] [Related]
20. Objective determination of the bioavailability of dermocorticoids--influence of the formulation.
Poelman MC; Leveque JL; Le Gall F
Br J Dermatol; 1984 Jul; 111 Suppl 27():158-62. PubMed ID: 6743548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
